Skip to main content

Abstract

In this report we give the survival data on 52 patients with stage I cancer of the lung who have been treated in Ottawa. A year has passed since the last figures for survival were published [15, 16]. We also indicate survival data for the small numbers of patients who were included in this study and who had either stage II or stage III disease. The rationale and design of this study has been reported in detail [14] as has the preparation and characterization of antigens used for immunisation [6]. The usefulness of such antigens in monitoring patients progress following curative surgery has also been reported [16].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Cutler, S. J., Ederer, F.: Maximum utilization of the Life Table Method in analyzing survival. J. Chronic Dis. 8, 699–712 (1958).

    Article  PubMed  CAS  Google Scholar 

  2. Frost, M. J., Rogers, G. T., Bagshawe, K. D.: Extraction and preliminary characterization of a human bronchogenic carcinoma antigen. Br. J. Cancer 31, 379–386 (1975).

    Article  PubMed  CAS  Google Scholar 

  3. Gaffar, S. A., Braatz, J. A., Kortright, K. H., Princier, G. L., Herberman, R. B., McIntire, K. R.: Isolation and characterisation of a human lung tumour associated antigen and developement of a radio immunoassay. A.A.C.R. Abs. 424, 106 (1978) 69th Annual Meeting.

    Google Scholar 

  4. Hollinshead, A. C., Stewart, T. H. M., Herberman, R. B.: Delayed hypersensitivity reactions to soluble membrane antigens of human malignant lung cells. J. Natl. Cancer Inst. 52, 327–338 (1974).

    PubMed  CAS  Google Scholar 

  5. Hollinshead, A. C., Sega, E., Stewart, T. H. M.: A comparison of lung cancer antigens. Tumori 6, 125–128 (1975).

    Google Scholar 

  6. Hollinshead, A. C., Stewart, T. H. M.: Lung tumour antigens. In: Proc. 3rd Int. Symp. Cancer Detection Prevention. Nieburg, H. E. (ed.). Basel: E. Karger (in press) (1977).

    Google Scholar 

  7. Kourounakis, L., Kapusta, M. A.: Restoration of diminished T-cell function in adjuvant induced disease by methotrexate. J. Rheumatol. 3, 346–354 (1976).

    PubMed  CAS  Google Scholar 

  8. Miller, A. B.: Personal communication. (1978).

    Google Scholar 

  9. Mohr, J. A., Nordquist, R. E., Rhoades, E. R., Coalson, R. E., Coalson, J. J.: Alveolar cell carcinoma-like antigen and antibodies in patients with Alveolar cell carcinoma and other cancers. Cancer Res. 34, 1904–1907 (1974).

    PubMed  CAS  Google Scholar 

  10. Mountain, C. F., Carr, D. T., Anderson, W. A. D.: A system for the clinical staging of lung cancer. Am. J. Roentgenol. 120, 130–138 (1974).

    CAS  Google Scholar 

  11. Sega, E., Natali, P. G., Ricci, C., Mineo, C. T., Citro, G.: Lung cancer tumour associated antigens. Isolation by gel filtration and characterisation by immunodiffusion. IRCS 2, 1278 (1974).

    CAS  Google Scholar 

  12. Sokal, J. E.: Measurements of delayed skin test response. New Engl. J. Med. 293, 501–502 (1975).

    Article  PubMed  CAS  Google Scholar 

  13. Stewart, T. H. M., Hollinshead, A. C., Herberman, R. B.: Soluble membrane antigens of human malignant lung cells. Cancer detection and prevention. Maltoni, C. (ed.), p. 638. Amsterdam: Excerpta Medica 1973.

    Google Scholar 

  14. Stewart, T. H. M., Hollinshead, A. C., Harris, J. E.: Immunochemotherapy of lung cancer. Ann. N.Y. Acad. Sci. 277, 436–466 (1976).

    Article  PubMed  CAS  Google Scholar 

  15. Stewart, T. H. M., Hollinshead, A. C., Harris, J., Raman, S., Belanger, R., Crepeau, A., Crook, A., Hirte, W., Hooper, D., Klaassen, D., Rapp, E., Sachs, H. J.: Specific Active Immunochemotherapy in lung cancer: A survival study. Can. J. Surg. 20, 370–377 (1977).

    PubMed  CAS  Google Scholar 

  16. Stewart, T. H. M., Hollinshead, A. C., Harris, J., Raman, S., Belanger, R., Crepeau, A., Crook, A., Hirte, W., Hooper, D., Klaassen, D., Rapp, E., Sachs, H. J.: A survival study of Specific Active Immunochemotherapy in lung cancer. Neoplasm Immunity: Solid tumour therapy. Cripsen, R. G. (ed.), pp. 37-48. Chicago: Franklin Institute 1977.

    Google Scholar 

  17. Viza, D., Louvier, M., Phillips, J., Boucheix, C., Guerin, R. A.: Solubilization of an antigen associated with certain bronchial tumours. Eur. J. Cancer 11, 765–770 (1975).

    Article  PubMed  CAS  Google Scholar 

  18. Watson, R. D., Smith, A. G., Levy, J. G.: The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchogenic carcinoma. Br. J. Cancer 32, 300–309 (1975).

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Stewart, T.H.M. et al. (1979). Specific Active Immunochemotherapy in Lung Cancer: A Survival Study. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81332-0_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81334-4

  • Online ISBN: 978-3-642-81332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics